“I think the best case scenario is we’re going to continue to see mortgage rates hover around six and a half to 7%,” said Jordan Jackson, a global market strategist at J.P. Morgan Asset Management. “So unfortunately for those homeowners who are looking for a bit of a reprieve on the mortgage rate side, that may not come to fruition,” Jordan said in an interview with CNBC.
Mortgage rates can be influenced by Fed policy. But the rates are more closely tied to long-term borrowing rates for government debt. The 10-year Treasury note yield has been increasing in recent months as investors consider more expansionary fiscal policies that may come from Washington in 2025. This, combined with signals sent from the market for mortgage-backed securities, determine the rates issued within new mortgages.
Economists at Fannie Mae say the Fed’s management of its mortgage-backed securities portfolio may contribute to today’s mortgage rates.
In the pandemic, the Fed bought huge amounts of assets, including mortgage-backed securities, to adjust demand and supply dynamics within the bond market. Economists also refer to the technique as “quantitative easing.”
Quantitative easing can reduce the spread between mortgage rates and Treasury yields, which leads to cheaper loan terms for home buyers. It can also provide opportunities for owners looking to refinance their mortgages. The Fed’s use of this technique in the pandemic brought mortgages rates to record lows in 2021.
“They were extra aggressive in 2021 with buying mortgage-backed securities. So, the [quantitative easing] was probably ill-advised at the time.” said Matthew Graham, COO of Mortgage News Daily.
In 2022, the Federal Reserve kicked off plans to reduce the balance of its holdings, primarily by allowing those assets to mature and “roll-off” of its balance sheet. This process is known as “quantitative tightening,” and it may add upward pressure on the spread between mortgage rates and Treasury yields.
“I think that’s one of the reasons the mortgage rates are still going in the wrong direction from the Federal Reserve’s standpoint,” said George Calhoun, director of the Hanlon Financial Systems Center at Stevens Institute of Technology.
UnitedHealth Group saw some of its insiders step in and purchase declining shares this week.
Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday.
Shares of UnitedHealth plunged nearly 11% to $274.35 on Thursday following a report in The Wall Street Journal that the Department of Justice is conducting a criminal investigation into possible Medicare fraud.
UnitedHealth Group , whose stock has been in a tailspin amid a tumultuous period for the health-care giant, saw some of its insiders step in and purchase declining shares this week. Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday, while Timothy Patrick Flynn and John Noseworthy, also directors, scooped up about 1,500 and 300 shares , respectively, on Wednesday, according to InsiderScore, which tracks regulatory filings from corporate insiders. Shares of UnitedHealth plunged nearly 11% to $274.35 on Thursday following a report in The Wall Street Journal that the Department of Justice is conducting a criminal investigation into possible Medicare fraud. The stock rebounded 6% Friday, cutting its weekly losses to 23%. UNH 5D mountain UnitedHealth The reported investigation also follows the surprise exit of UnitedHealth Group CEO Andrew Witty, who will be replaced by the company’s former longtime chief executive Stephen Hemsley. Shares of UnitedHealth Group are down roughly 43% this year following a string of setbacks for the company. The company has been grappling with a historic cyberattack, higher-than-expected medical costs and a torrent of public blowback after the murder of UnitedHealthcare CEO Brian Thompson.
U.S. Federal Reserve in Washington, DC, on January 30, 2024.
Mandel Ngan | Afp | Getty Images
The Federal Reserve will look to reduce its headcount by 10% over the next couple of years, including offering deferred resignation to some older employees, central bank chair Jerome Powell said in a memo.
“Experience here and elsewhere shows that it is healthy for any organization to periodically take a fresh look at its staffing and resources. The Fed has done that from time to time as our work, priorities, or external environment have changed,” Powell said in a memo obtained by CNBC.
The central bank chief added that he has instructed leaders throughout the Fed “to find incremental ways to consolidate functions where appropriate, modernize some business practices, and ensure that we are right-sized and able to meet our statutory mission.” One method for shrinking the staff will be to offer a voluntary deferred resignation program to employees of the Federal Reserve Board who would be fully eligible to retire at the end of 2027.
The central bank said in its 2023 annual report that it had just under 24,000 employees. A 10% reduction would bring that number below 22,000.
The memo comes as the Trump administration has pushed for cost cuts across civil service agencies, spearheaded by Elon Musk and the so-called Department of Government Efficiency. Musk has previously called the Fed “absurdly overstaffed.” Powell’s memo did not mention Musk or DOGE as a factor in the decision to shrink headcount.
The planned staff cuts were first reported by Bloomberg News.
Check out the companies making headlines in midday trading. Applied Materials — Shares of the semiconductor manufacturer dropped 6% after Applied Materials posted disappointing fiscal second-quarter revenue. The company’s revenue of $7.10 billion was below the LSEG consensus of $7.13 billion. Semiconductor revenue of $5.26 billion also disappointed the $5.31 billion analysts were looking for. Take-Two Interactive Software — The stock slid 1.8% after the video game company gave weaker-than-anticipated guidance for full-year bookings, expecting the figure to come between $5.9 billion and $6 billion. That missed the $7.82 billion StreetAccount consensus. Take-Two also projected bookings of between $1.25 billion and $1.30 billion for the current quarter, while analysts had penciled in $1.28 billion. Vistra — Shares of the power producer gained 3% after the company purchased seven natural gas facilities from Lotus Infrastructure Partners for $1.9 billion. The gas plants are located in the PJM market, New England, New York and California. Constellation Brands — Shares of the Corona and Modelo importer climbed 1.4% after Berkshire Hathaway disclosed doubling its stake in the company, putting its position at around $2.2 billion in value. Galaxy Digital — The Mike Novogratz-led crypto firm began trading at the Nasdaq on Friday, opening at $23.50 per share in a direct listing. Galaxy Digital has traded in Canada since 2020 . Cava — The eatery chain’s stock dropped more than 2% after the company reiterated its full-year guidance for same restaurant sales, implying a slowdown from first-quarter results. Cava said it achieved 10.8% same store sales growth. However, it maintained a full-year projection of 6% to 8% improvement in that category. Cava’s earnings per share of 22 cents for the period was ahead of projections for 14 cents per share, according to LSEG. Fiserv — The financial services provider jumped more than 4% as the stock recovered some of its steep losses for the week. Fiserv is down more than 9% this week and is one of the most oversold names on Wall Street, with a relative strength index below 30. Coinbase — The crypto exchange jumped more than 9%, recovering losses from the previous session. Some Wall Street analysts called the sell-off overdone and a buying opportunity . On Thursday, the company confirmed the Securities and Exchange Commission has been investigating whether it has misstated its user numbers , sending the stock down 7.2%. Novo Nordisk — Shares stumbled 3% after the pharmaceutical company announced that CEO Lars Fruergaard Jørgensen would be stepping down from his position , citing recent market challenges. Jørgensen, who was in the position for the last eight years, will remain “for a period to support a smooth transition to new leadership” as Novo Nordisk searches for a successor. Doximity — The health care platform issued weak guidance, sending the stock down 11.8%. Doximity expects adjusted EBITDA for the first quarter to come in between $71 million and $72 million. That’s short of the $74 million expected from analysts polled by StreetAccount. Revenue guidance for both the first quarter and full year also missed expectations. — CNBC’s Tanaya Macheel, Lisa Han, Jesse Pound and Michelle Fox contributed reporting.